Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from VSee Health ( (VSEE) ).
On October 9, 2025, VSee Health, Inc. entered into a note purchase agreement with an accredited institutional investor, issuing a secured note for $133,333.33 with a purchase price of $120,000, bearing an interest rate of 5% per annum and maturing on May 8, 2026. The agreement includes restrictions on variable rate transactions and mandates equal terms for future debt holders, while an amendment agreement ensures the note is fully secured by the company’s assets, potentially strengthening VSee Health’s financial stability and market position.
The most recent analyst rating on (VSEE) stock is a Sell with a $0.50 price target. To see the full list of analyst forecasts on VSee Health stock, see the VSEE Stock Forecast page.
Spark’s Take on VSEE Stock
According to Spark, TipRanks’ AI Analyst, VSEE is a Underperform.
VSee Health’s overall stock score is heavily impacted by financial instability and the risk of Nasdaq delisting. While there is some revenue growth, the negative equity, poor valuation, and bearish technical indicators contribute to a low score.
To see Spark’s full report on VSEE stock, click here.
More about VSee Health
VSee Health, Inc. operates in the healthcare industry, focusing on telemedicine solutions and digital health services.
Average Trading Volume: 477,779
Technical Sentiment Signal: Sell
Current Market Cap: $11.01M
For a thorough assessment of VSEE stock, go to TipRanks’ Stock Analysis page.